This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medifast (MED) Q3 Earnings: Coaches & OPTAVIA are Key Drivers
by Zacks Equity Research
Medifast's (MED) Q3 performance to gain from a sturdy coach base and advancement in the OPTAVIA brand.
Medifast (MED) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medifast (MED) Stock Moves -0.77%: What You Should Know
by Zacks Equity Research
Medifast (MED) closed the most recent trading day at $204.93, moving -0.77% from the previous trading session.
SYY or MED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYY vs. MED: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Champions Oncology, General Finance, Tilly's, Armstrong Flooring and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Champions Oncology, General Finance, Tilly's, Armstrong Flooring and Medifast
Wall Street Bulls to Flourish in Q4: 5 Solid Growth Picks
by Nalak Das
Despite trade war concerns, a robust U.S. economy and strong earnings results boosted investors' confidence in the stock markets.
Here's Why McCormick (MKC) is Sizzling in the Culinary Space
by Zacks Equity Research
McCormick's (MKC) top line gains from impressive brands performance. Yielding buyouts strengthens portfolio further.
Finding Campbell Bland? 3 Food Stocks to Please Your Palate
by Vrishali Bagree
While Campbell (CPB) is not performing well, there are some solid food players, which are gaining from focus on innovation, product launches and diversification.
Conagra (CAG) Q1 Earnings & Sales Lag Estimates, Stock Down
by Zacks Equity Research
Conagra's (CAG) Q1 earnings and sales grow year over year. However, higher input and transportation costs are hurdles.
Hain Celestial to Gain From Project Terra, Soft Sales a Woe
by Zacks Equity Research
Hain Celestial (HAIN) is expected to further gain from its Project Terra program and strategic acquisitions amid high expenses and soft U.S. segment sales.
Can Clorox's (CLX) Growth Strategies Offset Margin Woes?
by Zacks Equity Research
Clorox's (CLX) solid growth strategies, including 2020 Strategy, bode well. These initiatives are likely to offset margin pressures moving ahead.
Kraft Heinz's Canada Unit to Gain From Ethical Bean Buyout
by Zacks Equity Research
Kraft Heinz's (KHC) Canadian arm acquires Ethical Bean Coffee. This reflects Kraft Heinz's efforts to keep up with consumers' rising preference for healthy options.
5 Defensive Stocks to Buy as Trade Tensions Take a New Turn
by Ritujay Ghosh
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.
4 Reasons Why Hershey (HSY) Stock Should be in Your Portfolio
by Zacks Equity Research
The Hershey Company (HSY) is likely to benefit from focus on buyouts and solid cost-saving initiatives.
Will Strategic Initiatives Relieve B&G Foods of Cost Woes?
by Zacks Equity Research
B&G Foods (BGS) gains from well-chalked buyouts. However, rising fright expenses and debt levels are concerns.
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
by Zacks Equity Research
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
United Natural (UNFI) Q4 Earnings Up Y/Y, Stock Declines
by Zacks Equity Research
United Natural's (UNFI) Q4 earnings and sales increase year over year. However, both the metrics miss the Zacks Consensus Estimate.
5 Best-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Here are five marvelous liquid stocks that investors should snap up now for stellar returns.
MEDIFAST Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
MEDIFAST has been struggling lately, but the selling pressure may be coming to an end soon.
Looking for a Top Momentum Pick? Why Medifast (MED) is a Great Choice
by Zacks Equity Research
Does Medifast (MED) have what it takes to be a top stock pick for momentum investors? Let's find out.
General Mills (GIS) Tops Q1 Earnings, Misses Sales Estimates
by Zacks Equity Research
General Mills' (GIS) earnings mark its second straight beat, whereas sales miss estimates for the third consecutive time in Q1.
Kellogg Hits 52-Week High on Cost Cut Plans and Acquisitions
by Zacks Equity Research
Kellogg (K) gains from the RXBAR and Pringles acquisitions as well as the consolidation of Multipro. Its savings initiatives are also on track.
Sysco Up 40% in a Year: Can Momentum Sustain Amid Cost Woes?
by Zacks Equity Research
Sysco (SYY) is gaining from strength in its U.S. Foodservice operations and focus on strategies for 2020. However, cost inflation remains a threat to margins.
4 Reasons Why You Should Invest in Archer Daniels Stock
by Zacks Equity Research
Archer Daniels' (ADM) progresses on its portfolio management initiatives, cost-savings plan and Readiness program bodes well.